EGFR and breast cancer: Conversely, in the MCF-7 cells, the marked decrease observed in all experimental settings may stem from functional crosstalk between the EGFR and IGFR pathways, implying that their interplay could be vital for governing the cellular responses in ERα-positive breast cancer.